ExxonMobil Scholar in Residence, Harvard’s TH Chan School of Public Health

Regina Rabinovich is the ExxonMobil Scholar in Residence at Harvard’s TH Chan School of Public Health and director of the Malaria Elimination Initiative at the University of Barcelona’s ISGLOBAL, where she serves as the chair of the Malaria Eradication Scientific Alliance. She has more than 25 years’ experience in global health across research, public health, and philanthropic sectors, with a focus on strategy, global health product development, and the introduction and scale-up of tools and strategies that will impact endemic populations.

Before joining Harvard, she served as director of the infectious diseases program within the Bill & Melinda Gates Foundation’s Global Health Division, overseeing the development and implementation of strategies for preventing, treating, and controlling infectious diseases, most particularly malaria, pneumonia, diarrhea, and neglected infectious diseases. Dr. Rabinovich was chief of the Clinical and Regulatory Affairs Branch at the National Institute of Allergy and Infectious Diseases (NIAID), focusing on the development and evaluation of vaccines through a network of US clinical research units. She participated in the Children’s Vaccine Initiative, a global effort to prevent infectious diseases in children in the developing world.

In 1999, she became director of the PATH Malaria Vaccine Initiative, funded by the Bill & Melinda Gates Foundation, to advance development of promising malaria vaccine candidates. She serves on the boards of AERAS, a nonprofit biotech company focused on developing vaccines for tuberculosis, and the Sabin Vaccine Institute. She joined the CMMB Board in 2013. Dr. Rabinovich holds a medical degree from Southern Illinois University and a master’s degree in public health from the University of North Carolina.

She joined the CMMB Board of Directors in 2013 and serves as the Secretary and Chair of the Programs Committee.